Lauren Rusckowski Duprey

Chief Transformation Officer

Lauren Rusckowski Duprey (Chief Transformation Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $814K of TAK (47,586 sh × $17.10, as filed), executed Aug 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.5M

shares × price, as filed

Last traded

Sep 14

Filed Sep 15

Median ADV $57.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

TAK

Takeda Pharmaceutical Company Limited TAK · 0 buys · 2 sells 2 filings

Recent filings

TAKSALE Takeda Pharmaceutical Company Limited View filing → $640K
34,535 sh × $18.54
Exec Sep 14
Filed Sep 15 · 9:12 PM ET TAKSALE Takeda Pharmaceutical Company Limited View filing → $814K
47,586 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:51 PM ET